Klacid Iv

Clarithromycin, the active ingredient in Klacid Iv, is a macrolide antibiotic presented as an intravenous solution for intravenous use. It treats a range of serious bacterial infections in both adult and pediatric patients when oral therapy is unsuitable.

GNH USA supplies Klacid Iv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Clarithromycin is a macrolide antibiotic used to treat infections caused by susceptible bacteria. - Community‑acquired bacterial pneumonia: helps eradicate the causative pathogens and improve respiratory function. - Skin and soft‑tissue infections: reduces bacterial load in cellulitis, abscesses and wound infections. - Intra‑abdominal infections: assists in controlling mixed aerobic and anaerobic bacterial populations. - Severe upper respiratory tract infections: alleviates symptoms by targeting the responsible organisms. - Septicemia caused by susceptible strains: contributes to systemic infection control.

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: increased bowel movements, sometimes watery. - Abdominal pain: cramping or discomfort in the stomach area. - Altered taste: metallic or bitter sensation. - Headache: mild to moderate pain. - Rash: skin redness or itching.

Serious or Rare Side Effects: - Hepatic dysfunction: elevated liver enzymes or jaundice. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, angioedema. - Clostridioides difficile colitis: severe diarrhea with colitis. - Stevens‑Johnson syndrome: serious skin and mucous membrane disorder.

When using Klacid Iv, consider the following safety measures. - Renal impairment: assess kidney function and adjust therapy if needed. - Hepatic impairment: monitor liver enzymes during treatment. - QT prolongation risk: avoid in patients with known prolonged QT or electrolyte disturbances. - Drug interactions: review concomitant medications for potential interactions. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Clarithromycin can interact with several medicines; careful management is required.

Major Interactions (Avoid): - Cisapride: may cause serious cardiac arrhythmias. - Pimozide: increased risk of QT prolongation. - Terfenadine: can lead to life‑threatening arrhythmias. - Erythromycin and other macrolides: additive QT‑prolongation risk.

Moderate Interactions (Monitor Closely): - Statins (simvastatin, lovastatin): heightened risk of myopathy. - Warfarin: enhanced anticoagulant effect, monitor INR. - Theophylline: increased plasma levels, watch for toxicity.